Immunotherapies
have evolved
Harnessing more of the immune system for better cancer outcomes
Latest News

'Tis the season to join the phenomenal team at the @SCSMonash I joined the SCS family in September and cannot speak more highly of the people, culture, science, education & vision.

Seeking an outstanding Operations Manager & Comms Coordinator see links in comments. Pls RT.

We are on the hunt for a highly experienced Alliance Manager to support existing research and development alliances with industry and academic partners, as well as forge new business alliances and collaborations as we grow – come join us! https://www.linkedin.com/posts/onko-innate_pd-manager-alliance-management-activity-7005737902064242688-XnON?utm_source=share&utm_medium=member_ios

Load More...
 
Discover oNKo-innate
With our deep understanding of Natural Killer (NK) cells, we aim to be the first to master NK cell biology and therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.
Learn more
OUR APPROACH
Using powerful genomic approaches, we screen primary immune cells and cancer cells to understand their interaction within a tumor.
Learn more
lab1-webRes
o o
o
THE TEAM
We are driven by the challenge of engaging the immune system to fight cancer, and focused on delivering the first truly effective NK cell immunotherapies.
Find out who we are